4//SEC Filing
Haviland Kate 4
Accession 0000950170-25-091582
CIK 0001680581other
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 4:15 PM ET
Size
5.3 KB
Accession
0000950170-25-091582
Insider Transaction Report
Form 4
Haviland Kate
Director
Transactions
- Award
Stock Option (right to buy)
2025-06-26+36,000→ 36,000 totalExercise: $7.38Exp: 2035-06-25→ Common Stock (36,000 underlying)
Footnotes (1)
- [F1]This option was granted on June 26, 2025 and is scheduled to vest with respect to all shares on the first anniversary of the grant date or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date, subject to continued service.
Documents
Issuer
Fulcrum Therapeutics, Inc.
CIK 0001680581
Entity typeother
Related Parties
1- filerCIK 0001663022
Filing Metadata
- Form type
- 4
- Filed
- Jun 29, 8:00 PM ET
- Accepted
- Jun 30, 4:15 PM ET
- Size
- 5.3 KB